SCHEMBL20122502

SCHEMBL20122502

CC(=O)SC[C@H](NC(=O)C(C)(C)SC(=O)OCOC(=O)C(C)(C)C)C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20122448 0.93 — —
SCHEMBL20122504 0.90 CPB2 (0.30) —
SCHEMBL20122384 0.88 — —
SCHEMBL20122505 0.88 — —
SCHEMBL20122410 0.84 KDM4E (0.40) —
SCHEMBL20122446 0.84 — —
SCHEMBL20122522 0.83 — —
SCHEMBL20122500 0.82 ADRB2 (0.40) —
SCHEMBL20122523 0.81 CYP1A2 (0.37) —
SCHEMBL20122521 0.81 CYP1A2 (0.32) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9963428-B1 Bucillamine prodrugs, pharmaceutical compositions thereof, and methods of use Nguyen, Mark Quang (US) 2018-05-08 — — US disclosed
Send feedback